Attention! Information is for reference only!
Before taking the course, consult a doctor!
WEB SITE ONLY DIRECTORY. NOT PHARMACY! We do not sell medicines! None!
0 1 2 3 4 5 6 7 8 A B C D E F G H I J K L M N O P Q R S T U V W X Y

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Description of the medicine: Repaglinide (Repaglinide)

Repaglinide.

(+) - 2-Ethoxy-α - [[(S) -α-isobutyl-ortho-piperidino-benzyl] -carbamoyl] -para-toluic acid.

Synonym: NovoNorm, NovoNorm.

By blocking the ATP-dependent potassium channels of the pancreatic β-cells, it causes their depolarization, which leads to the opening of calcium channels and, as a result, an increase in the secretion of insulin.

Quickly and completely absorbed in the digestive tract, bioavailability is about 56%, C max - 1 h, T S - 1 h; Is subjected to intensive biotransformation in the liver, is excreted mainly with bile.

Apply for diabetes mellitus type II.

Assign inside (before meals), starting with 0.0005 g (0.5 mg) 3 times a day, increasing the dose depending on the glycemia no earlier than 1-2 weeks. The maximum single and daily doses are 0.004 and 0.016 g (4 and 16 mg), respectively. Can be combined with metformin.

Possible side effects: hypoglycemic reactions, dyspepsia, visual acuity.

The drug is contraindicated in diabetic coma, expressed violations of the liver and kidneys, pregnancy and lactation.

Product: tablets of 0.0005; 0.001 and 0.002 g (0.5, 1 and 2 mg) (N. 15, 30).